Seoul Pharma Co Ltd - ESG Rating & Company Profile powered by AI
This report of Seoul Pharma Co Ltd uses data from across the web as well as from available disclosures by Seoul Pharma Co Ltd. The SDG rating for Seoul Pharma Co Ltd indicates the company's transparency towards the United Nations SDGs. This webpage is a zero-cost ESG report for Seoul Pharma Co Ltd.
Seoul Pharma Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Seoul Pharma Co Ltd | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Seoul Pharma Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Seoul Pharma Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Seoul Pharma Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Seoul Pharma Co Ltd offer flexible work?
Sign up for free to unlockDoes Seoul Pharma Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Seoul Pharma Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Seoul Pharma Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose water use targets?
Sign up for free to unlockDoes Seoul Pharma Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Seoul Pharma Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Seoul Pharma Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Seoul Pharma Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Seoul Pharma Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Seoul Pharma Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Seoul Pharma Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Seoul Pharma Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Seoul Pharma Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Seoul Pharma Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Seoul Pharma Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Seoul Pharma Co., Ltd manufactures and distributes pharmaceutical products in South Korea and internationally. It provides Orally Disintegrating Film (ODF), a thin film that provides an alternative to orally disintegrating tablets with modifications. The company offers ODF products for therapeutic areas, including urology, neurology, nutrition, endocrinology, and OB/GY. Its products include VULTEUM and VULTIS for erectile dysfunction; ARTPEZIL for Alzheimer' disease; OBCARE to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency; and CH.V for collagen, hyaluronic acid, and vitamin C, as well as products for schizophrenia, vitamin B, and fatigue and immunity. The company was founded in 1976 and is headquartered in Seoul, South Korea.